Fresenius Medical Care (NYSE:FMS) Sees Strong Trading Volume – Should You Buy?

Fresenius Medical Care AG (NYSE:FMS) shares saw unusually-high trading volume on Wednesday . Approximately 740,733 shares were traded during trading, an increase of 138% from the previous session’s volume of 310,951 shares.The stock last traded at $24.66 and had previously closed at $24.47.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. StockNews.com raised Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a report on Wednesday, February 5th. Bank of America upgraded Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a research report on Monday, December 2nd. Finally, Truist Financial upped their price target on Fresenius Medical Care from $23.00 to $25.00 and gave the company a “hold” rating in a research report on Monday, January 6th.

Fresenius Medical Care Trading Down 1.4 %

The company has a current ratio of 1.37, a quick ratio of 1.02 and a debt-to-equity ratio of 0.42. The firm has a 50-day moving average of $23.82 and a 200 day moving average of $22.31. The company has a market cap of $14.25 billion, a P/E ratio of 20.07, a price-to-earnings-growth ratio of 0.76 and a beta of 0.99.

Institutional Investors Weigh In On Fresenius Medical Care

Several institutional investors and hedge funds have recently made changes to their positions in the business. Millennium Management LLC boosted its position in shares of Fresenius Medical Care by 5,297.5% during the 4th quarter. Millennium Management LLC now owns 722,238 shares of the company’s stock valued at $16,351,000 after purchasing an additional 708,857 shares in the last quarter. Integral Health Asset Management LLC boosted its holdings in Fresenius Medical Care by 33.3% in the fourth quarter. Integral Health Asset Management LLC now owns 600,000 shares of the company’s stock worth $13,584,000 after acquiring an additional 150,000 shares in the last quarter. Northern Trust Corp boosted its holdings in Fresenius Medical Care by 45.9% in the fourth quarter. Northern Trust Corp now owns 362,190 shares of the company’s stock worth $8,200,000 after acquiring an additional 113,953 shares in the last quarter. Moran Wealth Management LLC boosted its holdings in Fresenius Medical Care by 9.1% in the fourth quarter. Moran Wealth Management LLC now owns 254,710 shares of the company’s stock worth $5,767,000 after acquiring an additional 21,334 shares in the last quarter. Finally, ABC Arbitrage SA bought a new position in Fresenius Medical Care in the fourth quarter worth approximately $4,215,000. Institutional investors own 8.37% of the company’s stock.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.